Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹1000 |
Expense Ratio | 0.83 | 0.13 |
NAV | ₹16.06 | ₹31.70 |
Fund Started | 11 Feb 2022 | 19 Jun 2018 |
Fund Size | ₹366.32 Cr | ₹2315.59 Cr |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -2.37% | -5.90% |
3 Year | 15.66% | 27.54% |
5 Year | - | 32.06% |
1 Year
3 Year
5 Year
Equity | 99.84% | 0.00% |
Cash | 0.16% | 100.00% |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Bosch Ltd. | 1.29% |
Eternal Ltd. | 1.20% |
Torrent Pharmaceuticals Ltd. | 1.17% |
Varun Beverages Ltd. | 1.15% |
Dabur India Ltd. | 1.12% |
Hindustan Unilever Ltd. | 1.12% |
JIO Financial Services Ltd. | 1.10% |
Apollo Hospitals Enterprise Ltd. | 1.08% |
Godrej Consumer Products Ltd. | 1.08% |
Ambuja Cements Ltd. | 1.07% |
Name | Nirman S. Morakhia | Kayzad Eghlim |
Start Date | 15 Feb 2023 | 03 Dec 2021 |
Name
Start Date
Description | The scheme seeks to generate returns that are commensurate (before fees and expenses) with the performance of the NIFTY 100 Equal Weight Index TRI (Underlying Index), subject to tracking error. | The scheme seeks to generate returns by investing in units of BHARAT 22 ETF. |
Launch Date | 11 Feb 2022 | 19 Jun 2018 |
Description
Launch Date